fda news tirzepatide says the weight-loss drug shortage is over Is Tirzepatide FDA Approved?

It is important to understand that there is no official, direct pharmacological link between tirzepatide and menstrual cycle disruption listed in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA)

Last reviewed: May 18, 2026 Last updated: May 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma

By the second and third weeks, many patients feel significantly better and may return to light, nonphysically demanding work if cleared